BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12555992)

  • 41. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
    Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
    Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microsatellite instability and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient.
    Ichikawa Y; Tsunoda H; Takano K; Oki A; Yoshikawa H
    Jpn J Clin Oncol; 2002 Mar; 32(3):110-2. PubMed ID: 11956307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.
    Percesepe A; Borghi F; Menigatti M; Losi L; Foroni M; Di Gregorio C; Rossi G; Pedroni M; Sala E; Vaccina F; Roncucci L; Benatti P; Viel A; Genuardi M; Marra G; Kristo P; Peltomäki P; Ponz de Leon M
    J Clin Oncol; 2001 Oct; 19(19):3944-50. PubMed ID: 11579115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.
    Ponz de Leon M; Benatti P; Di Gregorio C; Pedroni M; Losi L; Genuardi M; Viel A; Fornasarig M; Lucci-Cordisco E; Anti M; Ponti G; Borghi F; Lamberti I; Roncucci L
    Br J Cancer; 2004 Feb; 90(4):882-7. PubMed ID: 14970868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
    Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
    J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
    Shia J; Ellis NA; Paty PB; Nash GM; Qin J; Offit K; Zhang XM; Markowitz AJ; Nafa K; Guillem JG; Wong WD; Gerald WL; Klimstra DS
    Am J Surg Pathol; 2003 Nov; 27(11):1407-17. PubMed ID: 14576473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.
    Reyes CM; Allen BA; Terdiman JP; Wilson LS
    Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer.
    Stone JG; Robertson D; Houlston RS
    J Clin Pathol; 2001 Jun; 54(6):484-7. PubMed ID: 11376026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
    Søreide K
    Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
    Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS
    Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability.
    Komura K; Masuda H; Esumi M
    Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer.
    Capozzi E; Della Puppa L; Fornasarig M; Pedroni M; Boiocchi M; Viel A
    Eur J Cancer; 1999 Feb; 35(2):289-95. PubMed ID: 10448273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.
    Cai KQ; Albarracin C; Rosen D; Zhong R; Zheng W; Luthra R; Broaddus R; Liu J
    Hum Pathol; 2004 May; 35(5):552-9. PubMed ID: 15138928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of cyclooxygenase-2 and relationship with mismatch repair gene and microsatellite instability in hereditary non-polyposis colorectal cancer].
    Zhang YH; Sheng JQ; Geng HG; Han M; Huang JS; Mu H; Han WL; Chen JG; Niu HL; Li AQ; Wu ZT; Li SR
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1377-81. PubMed ID: 19671325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.